Aichi Cancer Center
愛知県がんセンター
Japan
1 December 2019 - 30 November 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Aichi Cancer Center published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
12 | 1.19 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 12 | 1.19 | |
Chemistry | 1 | 0.10 |
Top articles by Altmetric score in current window
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics
2020-01-07
Antitumor activity of crizotinib in lung cancers harboring a exon 14 alteration
Nature Medicine
2020-01-13
Genomic characterization of malignant progression in neoplastic pancreatic cysts
Nature Communications
2020-08-14
1 December 2019 - 30 November 2020
International vs. domestic collaboration by Share
- 46.68% Domestic
- 53.32% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (64 total)
- Aichi Cancer Center, Japan
- Domestic institution
-
Nagoya University, Japan
(1.43)
-
Hokkaido University, Japan
(0.95)
-
Okayama University, Japan
(0.93)
-
National Cancer Center (NCC), Japan
(0.92)
-
RIKEN, Japan
(0.47)
-
Osaka University, Japan
(0.41)
-
Kyoto University, Japan
(0.38)
-
The University of Tokyo (UTokyo), Japan
(0.38)
-
Japanese Foundation for Cancer Research (JFCR), Japan
(0.25)
-
Tohoku University, Japan
(0.23)
Top 10 international collaborators by Share (425 total)
- Aichi Cancer Center, Japan
- Foreign institution
-
University of Cambridge, United Kingdom (UK)
(0.51)
-
Johns Hopkins Medicine (JHM), JHU, United States of America (USA)
(0.39)
-
Centre for Cancer Genetic Epidemiology (CCGE), University of Cambridge, United Kingdom (UK)
(0.32)
-
Harvard University, United States of America (USA)
(0.31)
-
Pfizer Inc., United States of America (USA)
(0.29)
-
Vanderbilt University (VU), United States of America (USA)
(0.27)
-
University of Southern California (USC), United States of America (USA)
(0.27)
-
Johns Hopkins University (JHU), United States of America (USA)
(0.26)
-
Medical Research Council (MRC), United Kingdom (UK)
(0.25)
-
National Institutes of Health (NIH), United States of America (USA)
(0.20)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Affiliated joint institutions and consortia

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.